2 news items
Brightcove Announces Financial Results for First Quarter Fiscal Year 2024
BCOV
8 May 24
)
Research
AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying
AIM
BCOV
CIA
25 Mar 24
focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases.
Check This Out
- Prev
- 1
- Next